Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin A null mouse

Endocrinology

Volumn 150, Issue 11, 2009, Pages 5027-5035

  Gayen, Jiaur R ^a   Gu, Yusu ^a   O'Connor, Daniel T ^a,b,c   Mahata, Sushil K ^a,c,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATROPINE; CATECHOLAMINE; CATESTATIN; CHROMOGRANIN A; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PROPRANOLOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR FUNCTION; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE RELEASE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DEPRESSOR RESPONSE; DIASTOLIC BLOOD PRESSURE; HEART RATE; HYPERTENSION; IMMOBILIZATION STRESS; MOUSE; NONHUMAN; PARASYMPATHETIC TONE; PHYSIOLOGICAL PROCESS; PRESSOR RESPONSE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CATECHOLAMINES; CHROMOGRANIN A; HEART RATE; HYPERTENSION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; PROPRANOLOL;

EID: 70350277703     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0429     Document Type: Article

References (51)

1. Taupenot L, Harper KL, O'Connor DT 2003 Mechanisms of disease: the chromogranin-secretogranin family. N Engl J Med 348:1134-1149
2. Takiyyuddin MA, Cervenka JH, Hsiao RJ, Barbosa JA, Parmer RJ, O'Connor DT 1990 Chromogranin A. Storage and release in hypertension. Hypertension 15:237-246
3. Takiyyuddin MA, Parmer RJ, Kailasam MT, Cervenka JH, Kennedy B, Ziegler MG, Lin MC, Li J, Grim CE, Wright FA, O'Connor DT 1995 Chromogranin A in human hypertension. Influence of heredity. Hypertension 26:213-220
4. O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ 2002 Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 20:1335-1345 (Pubitemid 34925678)
5. Rao F, Wen G, Gayen JR, Das M, Vaingankar SM, Rana BK, Mahata M, Kennedy BP, Salem RM, Stridsberg M, Abel K, Smith DW, Eskin E, Schork NJ, Hamilton BA, Ziegler MG, Mahata SK, O'Connor DT 2007 Catecholamine release-inhibitory peptide catestatin [chromogranin A(352-372)]: naturally occurringaminoacid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation 115:2271-2281 (Pubitemid 46685895)
6. Mahapatra NR, O'Connor DT, Vaingankar SM, Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N, Kennedy BP, Ziegler MG, Ross Jr J, Mahata SK 2005 Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 115:1942-1952
7. Angelone T, Quintieri AM, Brar BK, Limchaiyawat PT, Tota B, Mahata SK, Cerra MC 2008 The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. Endocrinology 149:4780-4793
8. KvetnanskýR, Pacák K, Fukuhara K, Viskupic E, Hiremagalur B, Nankova B, Goldstein DS, Sabban EL, Kopin IJ 1995 Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. Ann NY Acad Sci 771:131-158
9. Kvetnansky R, McCarty R, Thoa NB, Lake CR, Kopin IJ 1979 Sympatho-adrenal responses of spontaneously hypertensive rats to immobilization stress. Am J Physiol 236:H457-H462 (Pubitemid 9146159)
10. Irvine RJ, White J, Chan R 1997 The influence of restraint on blood pressure in the rat. J Pharmacol Toxicol Methods 38:157-162 (Pubitemid 28121352)
11. McDougall SJ, Paull JR, Widdop RE, Lawrence AJ 2000 Restraint stress: differential cardiovascular responses in Wistar-Kyoto and spontaneously hypertensive rats. Hypertension 35:126-129 (Pubitemid 30054248)
12. Sabban EL, Schilt N, Serova LI, Masineni SN, Stier Jr CT 2009 Kinetics and persistence of cardiovascular and locomotor effects of immobilization stress and influence of ACTH treatment. Neuroendocrinology 89:98-108
13. Sohn HS, Park YN, Lee SR 2002 Effect of immobilization stress on brain polyamine levels in spontaneously hypertensive and Wistar-Kyoto rats. Brain Res Bull 57:575-579
14. Aars H 1968 Aortic baroreceptor activity in normal and hypertensive rabbits. Acta Physiol Scand 72:298-309
15. West MJ, Korner PI 1974 The baroreceptor-heart rate reflex in renal hypertension in the rabbit. Clin Exp Pharmacol Physiol 1:231-239
16. Bristow JD, Honour AJ, Pickering GW, Sleight P, Smyth HS 1969 Diminished baroreflex sensitivity in high blood pressure. Circulation 39:48-54
17. Goldstein DS 1983 Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension. Circulation 68:234-240
18. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G 1998 Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 31:68-72 (Pubitemid 28124694)
19. Parmer RJ, Cervenka JH, Stone RA 1992 Baroreflex sensitivity and heredity in essential hypertension. Circulation 85:497-503
20. Eskeland NL, Zhou A, Dinh TQ, Wu H, Parmer RJ, Mains RE, O'Connor DT 1996 Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway. J Clin Invest 98:148-156 (Pubitemid 26243831)
21. Biswas N, Vaingankar SM, Mahata M, Das M, Gayen JR, Taupenot L, Torpey JW, O'Connor DT, Mahata SK 2008 Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin. Endocrinology 149:749-757 (Pubitemid 351159350)
22. Biswas N, Rodriguez-Flores JL, Courel M, Gayen JR, Vaingankar SM, Mahata M, Torpey JW, Taupenot L, O'Connor DT, Mahata SK 2009 Cathepsin L co-localizes with chromogranin a in chromaffin vesicles to generate active peptides. Endocrinology 150:3547-3557
23. McDougall SJ, Lawrence AJ, Widdop RE 2005 Differential cardiovascular responses to stressors in hypertensive and normotensive rats. Exp Physiol 90:141-150
24. Farah VM, Joaquim LF, Morris M 2006 Stress cardiovascular/autonomic interactions in mice. Physiol Behav 89:569-575
25. Farah VM, Joaquim LF, Bernatova I, Morris M 2004 Acute and chronic stress influence blood pressure variability in mice. Physiol Behav 83:135-142 (Pubitemid 39387702)
26. Mahata SK, O'Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ 1997 Novel autocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 100:1623-1633 (Pubitemid 27425790)
27. Mahata SK, Mahata M, Wakade AR, O'Connor DT 2000 Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A344-364): Identification of amino acid residues crucial for activity. Mol Endocrinol 14:1525-1535 (Pubitemid 30834495)
28. Mahata SK, Mahata M, Wen G, Wong WB, Mahapatra NR, Hamilton BA, O'Connor DT 2004 The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses. Mol Pharmacol 66:1180-1191
29. Wen G, Mahata SK, Cadman P, Mahata M, Ghosh S, Mahapatra NR, Rao F, Stridsberg M, Smith DW, Mahboubi P, Schork NJ, O'Connor DT, Hamilton BA 2004 Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology. Am J Hum Genet 74:197-207 (Pubitemid 38168608)
30. Mahata SK, Mahapatra NR, Mahata M, Wang TC, Kennedy BP, Ziegler MG, O'Connor DT 2003 Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin. J Biol Chem 278:32058-32067 (Pubitemid 37048394)
31. Tjurmina OA, Armando I, Saavedra JM, Goldstein DS, Murphy DL 2002 Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology 143:4520-4526 (Pubitemid 35397591)
32. Montesinos MS, Machado JD, Camacho M, Diaz J, Morales YG, Alvarez de la Rosa D, Carmona E, Castañeyra A, Viveros OH, O'Connor DT, Mahata SK, Borges R 2008 The crucial role of chromogranins in storage and exocytosis revealed using chromaffin cells from chromogranin A null mouse. J Neurosci 28:3350-3358
33. Grouzmann E, Cavadas C, Grand D, Moratel M, Aubert JF, Brunner HR, Mazzolai L 2003 Blood sampling methodology is crucial for precise measurement of plasma catecholamines concentrations in mice. Pflugers Arch 447:254-258 (Pubitemid 38177741)
34. Lum C, Shesely EG, Potter DL, Beierwaltes WH 2004 Cardiovascular and renal phenotype in mice with one or two renin genes. Hypertension 43:79-86 (Pubitemid 38031914)
35. Diz DI, Westwood B, Bosch SM, Ganten D, Ferrario C 1998 NK1 receptor antagonist blocks angiotensin II responses in renin transgenic rat medulla oblongata. Hypertension 31:473-479 (Pubitemid 28124761)
36. Diz DI, Garcia-Espinosa MA, Gallagher PE, Ganten D, Ferrario CM, Averill DB 2008 Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats. J Cardiovasc Pharmacol 51:542-548
37. Cunha RS, Cabral AM, Vasquez EC 1993 Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. Am J Hypertens 6:806-809
38. Veelken R, Hilgers KF, Ditting T, Leonard M, Mann JF, Geiger H, Luft FC 1994 Impaired cardiovascular reflexes precede deoxycorticosterone acetate-salt hypertension. Hypertension 24:564-570 (Pubitemid 24337825)
39. Moyses MR, Cabral AM, Bissoli N, Vasquez EC 1994 Time course of changes in sigmoidal-fitting baroreceptor curves in one-kidney, one clip hypertensive rats. Hypertension 23:I87-92 (Pubitemid 24020426)
40. Peotta VA, Vasquez EC, Meyrelles SS 2001 Cardiovascular neural reflexes in L-NAME-induced hypertension in mice. Hypertension 38:555-559
41. Xue B, Pamidimukkala J, Hay M 2005 Sex differences in the development of angiotensin II-induced hypertension in conscious mice. Am J Physiol Heart Circ Physiol 288:H2177-H2184 (Pubitemid 40604103)
42. Carvalho TH, Lopes OU, Tolentino-Silva FR 2006 Baroreflex responses in neuronal nitric oxide synthase knockout mice (nNOS). Auton Neurosci 126-127:163-168 (Pubitemid 43816934)
43. Peotta VA, Gava AL, Vasquez EC, Meyrelles SS 2007 Evaluation of baroreflex control of heart rate in renovascular hypertensive mice. Can J Physiol Pharmacol 85:761-766 (Pubitemid 350144735)
44. Saleh TM, Connell BJ 1998 The parabrachial nucleus mediates the decreased cardiac baroreflex sensitivity observed following short-term visceral afferent activation. Neuroscience 87:135-146
45. Head GA 1994 Cardiac baroreflexes and hypertension. Clin Exp Pharmacol Physiol 21:791-802
46. Gava AL, Peotta VA, Cabral AM, Meyrelles SS, Vasquez EC 2004 Decreased baroreflex sensitivity in isoproterenol-treated mice with cardiac hypertrophy. Auton Neurosci 114:47-54
47. Minami N, Head GA 1993 Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats. J Hypertens 11:523-533 (Pubitemid 23154343)
48. Salgado HC, Barale AR, Castania JA, Machado BH, Chapleau MW, Fazan Jr R 2007 Baroreflex responses to electrical stimulation of aortic depressor nerve in conscious SHR. Am J Physiol Heart Circ Physiol 292:H593-H600
49. Janssen BJ, Leenders PJ, Smits JF 2000 Short-term and long-term blood pressure and heart rate variability in the mouse. Am J Physiol Regul Integr Comp Physiol 278:R215-R225 (Pubitemid 30182692)
50. Just A, Faulhaber J, Ehmke H 2000 Autonomic cardiovascular control in conscious mice. Am J Physiol Regul Integr Comp Physiol 279:R2214-R2221
51. Opthof T 2000 The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res 45:173-176